Head-to-head · Cost-Efficiency Index
Tablet Health vs Alinwell
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Tablet Health
Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list.
Visit Tablet HealthAlinwell
Readers who want to see the compounding certificates before they buy, and who will look past the advertised figure to the price that renews.
Visit AlinwellThe verdict
Tablet Health and Alinwell tie on the Cost-Efficiency Index at 57/100, so neither wins outright on the numbers. For most shoppers we'd start with Tablet Health (ranked #304, a hair above #305) — Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list. But Alinwell is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Tablet Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Tablet Health | Alinwell |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 57/100 |
| Semaglutide / mo | $199/mo (compounded) | $249/mo month-to-month (charged every 30 days; the advertised $149 is the first month only) |
| Tirzepatide / mo | $299/mo (compounded) | $299/mo month-to-month (charged every 30 days; the advertised $199 is the first month only) |
| Semaglutide / yr (modeled) | $2,388 | $2,988 |
| Tirzepatide / yr (modeled) | $3,588 | $3,588 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #304 | #305 |
Tablet Health
57/100Where the value is
- LegitScript Certified — seal displayed on the site
- Offers both oral-tablet and injectable forms of semaglutide AND tirzepatide, four distinct SKUs
- Published per-product pricing rather than a single vague 'starting at' figure: $179-$299/mo across the four variants
The tradeoffs
- States served are not published anywhere on the accessible site — eligibility is only revealed by completing the intake quiz
- The homepage's 'Flat monthly pricing starting at $149' banner cannot be tied to any of the four listed $179-$299 tiers
Alinwell
57/100Where the value is
- Links a certificate of analysis for each GLP-1 from the treatment page itself, naming the compounding pharmacy, the strength and the testing laboratory
- The monthly figure includes physician review, care coaching, a dietitian visit and expedited shipping, with no separate consultation or dose-change fee
- Three- and six-month rates are shown side by side at checkout rather than being quoted only on request
The tradeoffs
- Every advertised price is an introductory one: "from $149/mo" and "from $199/mo" are labeled "$100 off first month" at checkout, with $249 and $299 struck through beside them
- The three-month plan costs more per month than the advertised monthly figure ($219 against $149), because the advertised figure was never a rate
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.